Chimeric Antigen Receptor CAR T Cells
T cells engineered to express chimeric antigen receptors, commonly known as CAR T cells, have demonstrated the ability to help patients suffering from blood cancer.
Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
T cells engineered to express chimeric antigen receptors, commonly known as CAR T cells, have demonstrated the ability to help patients suffering from blood cancer.
A report on the experiment, which produced a mouse with 19 pairs of chromosomes – one fewer than natural – has been published in Science magazine.
New research from Cornell offers insights into a line of CRISPR systems, which could lead to promising antiviral and tissue engineering tools in animal and plants.
A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications.
George Church is a co-founder of Colossal Biosciences, which is attempting to develop an animal that closely resembles the giant creature.